AGMB

AgomAb Therapeutics NV
AGMB

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$32
225% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Leerink Partners
Leerink Partners
Thomas Smith
0% 1-yr AGMB win rate
3 Mar ‘26 28 days ago
JP Morgan
JP Morgan
Anupam Rama
0% 1-yr AGMB win rate
3 Mar ‘26 28 days ago
Morgan Stanley
Morgan Stanley
Judah Frommer
0% 1-yr AGMB win rate
3 Mar ‘26 28 days ago